At the news
? BEARISHIMPACT 7/10 PRESS-RELEASE filed Jul 17, 2026 at 07:00 ET
REGENXBIO priced a $100M underwritten public offering of 10M shares at $9.00/share plus 1.1M pre-funded warrants, representing ~17-20% dilution of existing shares. The offering closes July 20, with underwriters holding a 30-day option for an additional 1.67M shares. This capital raise provides cash runway but significantly dilutes current holders.
- Gross proceeds of ~$100M from 10,003,889 shares at $9.00/share and 1,111,111 pre-funded warrants at $8.9999/warrant
- Underwriters have 30-day option to purchase an additional 1,667,250 shares
- Offering expected to close July 20, 2026
- Joint book-runners: Morgan Stanley, J.P. Morgan, Leerink Partners, Mizuho
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access